The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Open accessAbstract
The inflammatory chemokines CXCL9, CXCL10 and CXCL11 are predominantly induced by interferon (IFN)-γ and share an exclusive chemokine receptor named CXCR3. With a prototype function of directing temporal and spatial migration of activated T cells and natural killer (NK) cells, and inhibitory effects on angiogenesis, these CXCR3 ligands have been implicated in infection, acute inflammation, autoinflammation and autoimmunity, as well as in cancer. Intense former research efforts led to recent and ongoing clinical trials using CXCR3 and CXCR3 ligand targeting molecules. Scientific evidence has claimed mutual redundancy, ligand dominance, collaboration or even antagonism, depending on the (patho)physiological context. Most research on their in vivo activity, however, illustrates that CXCL9, CXCL10 and CXCL11 each contribute to the activation and trafficking of CXCR3 expressing cells in a non-redundant manner. When looking into detail, one can unravel a multistep machinery behind final CXCR3 ligand functions. Not only can specific cell types secrete individual CXCR3 interacting chemokines in response to certain stimuli, but also the receptor and glycosaminoglycan (GAG) interactions, major associated intracellular pathways and susceptibility to processing by particular enzymes, amongst others, seem ligand-specific. Here, we overview major aspects of the molecular properties and regulatory mechanisms of IFN-induced CXCR3 ligands, and propose that their in vivo non-redundancy is a reflection of the unprecedented degree of versatility that seems inherent to the IFN-related CXCR3 chemokine system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes
Graves, C. L., Li, J., LaPato, M., Shapiro, M. R., Glover, S. C., Wallet, M. A., & Wallet, S. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00679 · Cited by 25
Westphal, G., Rihs, H., Schaffranek, A., Zeiler, T. A., Werfel, T., Heratizadeh, A., Dickel, H., Weißhaar, E., Bauer, A., Schliemann, S., et al. (2016) · Contact Dermatitis · doi:10.1111/cod.12623 · Cited by 24
Chemokines: role in immune cell traffic.
Moser, B. (2004) · PubMed · Cited by 23
Li, S., Pettersson, U. S., Hoorelbeke, B., Kołaczkowska, E., Schelfhout, K., Martens, E., Kubes, P., Damme, J. V., Phillipson, M., & Opdenakker, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104107 · Cited by 20
A Unique Palindromic Element Mediates Gamma Interferon Induction of mig Gene Expression
Wong, P. C., Severns, C. W., Guyer, N. B., & Wright, T. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.914-922.1994 · Cited by 20
Grujic, M., Matić, I. Z., Crnogorac, M. Đ., Velickovic, A. D., Kolundžija, B., Cordero, O. J., Juranić, Z. D., Prodanovic, S., Zlatanović, M., Babic, D. D., et al. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1279 · Cited by 19
The role of CXCR3 and its ligands in renal transplant outcome
Dabiri, S., Kariminik, A., & Kennedy, D. D. (2016) · European Cytokine Network · doi:10.1684/ecn.2016.0375 · Cited by 18
Manousou, P., Kolios, G. C., Drygiannakis, I., Pyrovolaki, K., Bourikas, L. A., Papadaki, H. Α., & Kouroumalis, E. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05486.x · Cited by 15
Scholten, D. J., Wijtmans, M., van Senten, J. R., Custers, H., Stunnenberg, A., de Esch, I. J. P., Smit, M. J., & Leurs, R. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.095265 · Cited by 14
Sun, C. C., Zhu, X., Tao, T., Zhang, D., Wang, Y., Xu, H. X., Ren, Y., & Wang, Y. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.02.001 · Cited by 12
(1995) · PubMed
Cited by
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
House, I. G., Savas, P., Lai, J., Chen, A. X. Y., Oliver, A. J., Teo, Z. L., Todd, K. L., Henderson, M. A., Giuffrida, L., Petley, E. V., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1868 · Cited by 790
“CXCL11 binds to CXCR3 with the highest affinity, followed by CXCL10 and CXCL9 (15, 16) and notably CXCL11 binds to the CXCR3 receptor at a distinct binding site of the receptor (17), potentially leading to diverse signaling outcomes (18).”
BackgroundNeutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Self-citationMouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Israelow, B., Song, E., Mao, T., Lu, P., Meir, A., Liu, F., Alfajaro, M. M., Wei, J., Dong, H., Homer, R. J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201241 · Cited by 415
Commensal-driven immune zonation of the liver promotes host defence
Gola, A., Dorrington, M. G., Speranza, E., Sala, C., Shih, R. M., Radtke, A. J., Wong, H. S., Baptista, A. P., Hernandez, J. M., Castellani, G., et al. (2021) · Nature · doi:10.1038/s41586-020-2977-2 · Cited by 278
Metadata
- Authors
- Metzemaekers, M., Vanheule, V., Janssens, R., Struyf, S., & Proost, P.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-01-15
- Volume
- 8
- Pages
- 1970-1970
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2782848416
- Cited by
- 328
- References
- 211
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.